These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 26623270)

  • 1. Treatment of Nonalcoholic Fatty Liver Disease: The Role of Medical, Surgical, and Endoscopic Weight Loss.
    Popov VB; Lim JK
    J Clin Transl Hepatol; 2015 Sep; 3(3):230-8. PubMed ID: 26623270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role Bariatric Surgery and Endobariatric Therapies in Nonalcoholic Steatohepatitis.
    Yeoh A; Wong R; Singal AK
    Clin Liver Dis; 2023 May; 27(2):413-427. PubMed ID: 37024216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medical and Surgical Treatment Options for Nonalcoholic Steatohepatitis.
    Corey KE; Rinella ME
    Dig Dis Sci; 2016 May; 61(5):1387-97. PubMed ID: 26942734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonalcoholic fatty liver disease and diabetes.
    Bellini MI; Urciuoli I; Del Gaudio G; Polti G; Iannetti G; Gangitano E; Lori E; Lubrano C; Cantisani V; Sorrenti S; D'Andrea V
    World J Diabetes; 2022 Sep; 13(9):668-682. PubMed ID: 36188142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Similarities and differences between pediatric and adult nonalcoholic fatty liver disease.
    Crespo M; Lappe S; Feldstein AE; Alkhouri N
    Metabolism; 2016 Aug; 65(8):1161-71. PubMed ID: 26961580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of bariatric surgery in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
    Shouhed D; Steggerda J; Burch M; Noureddin M
    Expert Rev Gastroenterol Hepatol; 2017 Sep; 11(9):797-811. PubMed ID: 28712339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical epidemiology and disease burden of nonalcoholic fatty liver disease.
    Perumpail BJ; Khan MA; Yoo ER; Cholankeril G; Kim D; Ahmed A
    World J Gastroenterol; 2017 Dec; 23(47):8263-8276. PubMed ID: 29307986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current treatments in nonalcoholic steatohepatitis.
    Torres DM; Harrison SA
    Curr Treat Options Gastroenterol; 2007 Dec; 10(6):425-34. PubMed ID: 18221603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of Long Non-Coding RNAs (lncRNAs) in the Development and Progression of Fibrosis Associated with Nonalcoholic Fatty Liver Disease (NAFLD).
    Hanson A; Wilhelmsen D; DiStefano JK
    Noncoding RNA; 2018 Aug; 4(3):. PubMed ID: 30134610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonalcoholic fatty liver disease: a systematic review.
    Rinella ME
    JAMA; 2015 Jun; 313(22):2263-73. PubMed ID: 26057287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonalcoholic fatty liver disease/steatohepatitis: epidemiology, pathogenesis, clinical presentation and treatment.
    Milić S; Stimac D
    Dig Dis; 2012; 30(2):158-62. PubMed ID: 22722431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonalcoholic-Fatty-Liver-Disease and Nonalcoholic Steatohepatitis: Successful Development of Pharmacological Treatment Will Depend on Translational Research.
    Gottlieb A; Mosthael W; Sowa JP; Canbay A
    Digestion; 2019; 100(2):79-85. PubMed ID: 30537758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current Treatment of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis.
    Hung CK; Bodenheimer HC
    Clin Liver Dis; 2018 Feb; 22(1):175-187. PubMed ID: 29128055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of a preoperative low-calorie diet on liver histology in patients with fatty liver disease undergoing bariatric surgery.
    Wolf RM; Oshima K; Canner JK; Steele KE
    Surg Obes Relat Dis; 2019 Oct; 15(10):1766-1772. PubMed ID: 31558407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.
    Takahashi Y; Fukusato T
    World J Gastroenterol; 2014 Nov; 20(42):15539-48. PubMed ID: 25400438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonalcoholic fatty liver disease and cardiovascular disease.
    Hyogo H; Chayama K; Yamagishi S
    Curr Pharm Des; 2014; 20(14):2403-11. PubMed ID: 23844815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic transcriptome signatures in patients with varying degrees of nonalcoholic fatty liver disease compared with healthy normal-weight individuals.
    Suppli MP; Rigbolt KTG; Veidal SS; Heebøll S; Eriksen PL; Demant M; Bagger JI; Nielsen JC; Oró D; Thrane SW; Lund A; Strandberg C; Kønig MJ; Vilsbøll T; Vrang N; Thomsen KL; Grønbæk H; Jelsing J; Hansen HH; Knop FK
    Am J Physiol Gastrointest Liver Physiol; 2019 Apr; 316(4):G462-G472. PubMed ID: 30653341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minimally invasive percutaneous endovascular therapies in the management of complications of non-alcoholic fatty liver disease (NAFLD): A case report.
    Salsamendi J; Pereira K; Kang K; Fan J
    J Radiol Case Rep; 2015 Sep; 9(9):36-43. PubMed ID: 26629307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonalcoholic fatty liver disease in individuals with severe obesity.
    Haynes P; Liangpunsakul S; Chalasani N
    Clin Liver Dis; 2004 Aug; 8(3):535-47, viii. PubMed ID: 15331062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonalcoholic Fatty Liver Disease: Clinical Features and Pathogenesis.
    Basaranoglu M; Neuschwander-Tetri BA
    Gastroenterol Hepatol (N Y); 2006 Apr; 2(4):282-291. PubMed ID: 28286458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.